ClearPoint Neuro (CLPT) Notes Payables (2011 - 2024)

ClearPoint Neuro (CLPT) reported Notes Payables of $10.0 million for Q2 2024, little changed sequentially from $10.0 million in Q1 2024.

ClearPoint Neuro (CLPT) Notes Payables (2011 - 2024) Analysis & Trends

ClearPoint Neuro (CLPT) has 9 years of Notes Payables data on file, last reported at $10.0 million in Q2 2024.

For the quarter ending Q2 2024, Notes Payables changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Jun 2024 stood at $10.0 million (changed N/A YoY), and the FY2017 full-year result was $95786.0, down 26.98% from the prior year.
Notes Payables held at $10.0 million in Q2 2024, from $10.0 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $10.0 million in Q2 2024 to a low of $10.0 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	ClearPoint Neuro	434.51 Mn	398.91 Mn	7.76 Mn

Download Data